WHO treatment guidelines against leprosy: a focus on pharmacovigilance.

Pugazhenthan Thangaraju; Sajitha Venkatesan

doi:10.17826/cumj.511810

EN TR

WHO treatment guidelines against leprosy: a focus on pharmacovigilance.

Öz

A focus on Pharmacovigilance

Anahtar Kelimeler

leprosy,guideline,pharmacovigilance

Kaynakça

1. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. http://nlep.nic.in/pdf/WHO%20Guidelines%20for%20leprosy.pdf Retrieved on 10/01/2019.
2. Pharmacovigilance. https: //www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/. Accessed on 11/01/2019.
3. Thangaraju P, Venkatesan S, Tamilselvan T, Sivashanmugam E, Showkath Ali M K. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring among medical professionals attending Central Leprosy Institute. Mustansiriya Med J 2018;17:63-8

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Editöre Mektup

Yazarlar

Pugazhenthan Thangaraju ^*
0000-0002-4090-2004
India

Sajitha Venkatesan Bu kişi benim
0000-0001-9147-2553
India

Yayımlanma Tarihi

30 Haziran 2019

Gönderilme Tarihi

1 Ocak 2019

Kabul Tarihi

12 Ocak 2019

Yayımlandığı Sayı

Yıl 2019 Cilt: 44 Sayı: 2

DOI

https://doi.org/10.17826/cumj.511810

IZ

https://izlik.org/JA36LE86PF

APA

Thangaraju, P., & Venkatesan, S. (2019). WHO treatment guidelines against leprosy: a focus on pharmacovigilance. Cukurova Medical Journal, 44(2), 701-702. https://doi.org/10.17826/cumj.511810

AMA

1.Thangaraju P, Venkatesan S. WHO treatment guidelines against leprosy: a focus on pharmacovigilance. Cukurova Med J. 2019;44(2):701-702. doi:10.17826/cumj.511810

Chicago

Thangaraju, Pugazhenthan, ve Sajitha Venkatesan. 2019. “WHO treatment guidelines against leprosy: a focus on pharmacovigilance”. Cukurova Medical Journal 44 (2): 701-2. https://doi.org/10.17826/cumj.511810.

EndNote

Thangaraju P, Venkatesan S (01 Haziran 2019) WHO treatment guidelines against leprosy: a focus on pharmacovigilance. Cukurova Medical Journal 44 2 701–702.

IEEE

[1]P. Thangaraju ve S. Venkatesan, “WHO treatment guidelines against leprosy: a focus on pharmacovigilance”., Cukurova Med J, c. 44, sy 2, ss. 701–702, Haz. 2019, doi: 10.17826/cumj.511810.

ISNAD

Thangaraju, Pugazhenthan - Venkatesan, Sajitha. “WHO treatment guidelines against leprosy: a focus on pharmacovigilance”. Cukurova Medical Journal 44/2 (01 Haziran 2019): 701-702. https://doi.org/10.17826/cumj.511810.

JAMA

1.Thangaraju P, Venkatesan S. WHO treatment guidelines against leprosy: a focus on pharmacovigilance. Cukurova Med J. 2019;44:701–702.

MLA

Thangaraju, Pugazhenthan, ve Sajitha Venkatesan. “WHO treatment guidelines against leprosy: a focus on pharmacovigilance”. Cukurova Medical Journal, c. 44, sy 2, Haziran 2019, ss. 701-2, doi:10.17826/cumj.511810.

Vancouver

1.Pugazhenthan Thangaraju, Sajitha Venkatesan. WHO treatment guidelines against leprosy: a focus on pharmacovigilance. Cukurova Med J. 01 Haziran 2019;44(2):701-2. doi:10.17826/cumj.511810